Analytical Data
-
Gene name
PERLD1
- Application
-
Alternative Names
PGAP3; CAB2; PERLD1; UNQ546/PRO1100; Post-GPI attachment to proteins factor 3; COS16 homolog; hCOS16; Gene coamplified with ERBB2 protein; PER1-like domain-containing protein 1
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96FM1
-
Expression Region
1-320 aa
-
AA Sequence
MAGLAARLVLLAGAAALASGSQGDREPVYRDCVLQCEEQNCSGGALNHFRSRQPIYMSLAGWTCRDDCKYECMWVTVGLYLQEGHKVPQFHGKWPFSRFLFFQEPASAVASFLNGLASLVMLCRYRTFVPASSPMYHTCVAFAWVSLNAWFWSTVFHTRDTDLTEKMDYFCASTVILHSIYLCCVRTVGLQHPAVVSAFRALLLLMLTVHVSYLSLIRFDYGYNLVANVAIGLVNVVWWLAWCLWNQRRLPHVRKCVVVVLLLQGLSLLELLDFPPLFWVLDAHAIWHISTIPVHVLFFSFLEDDSLYLLKESEDKFKLD
-
Molecular Weight
62.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PERLD1 (Perl domain-containing protein 1) is a recently identified protein that has garnered attention in the field of molecular biology due to its potential roles in various cellular processes, including cell proliferation, differentiation, and apoptosis. Emerging evidence suggests that PERLD1 may play a significant role in the regulation of gene expression and cellular signaling pathways, implicating its involvement in developmental biology and disease states, such as cancer. The interest in PERLD1 has been further fueled by studies linking its dysregulation to various pathological conditions, highlighting the need for a deeper understanding of its functional mechanisms. Recent advances in recombinant protein technologies have enabled researchers to produce and characterize PERLD1 in vitro, facilitating the investigation of its structural and functional properties. By generating recombinant PERLD1, scientists aim to elucidate its biological role and interactions at the molecular level, thus providing insights into its contributions to health and disease. Current research focuses on determining the specific domains and motifs of PERLD1 that are critical for its function, as well as exploring its interactions with other proteins and nucleic acids. Given the potential of PERLD1 as a biomarker or therapeutic target, ongoing studies are essential to unravel its complex biology and assess its implications in human health, paving the way for future therapeutic strategies. Overall, the study of PERLD1 represents a promising avenue for innovative research in protein science and molecular medicine.
